Grant: Banting Postdoctoral Fellowship Program
Université de Montréal
$140,000.00
Cellular senescence in diabetic retinopathy
FY 2017-18
Summary
Diabetic retinopathy (DR) is the most prominent complication of diabetes and the leading cause of severe visual loss. Diabetic retinopathy has largely been perceived as a microvascular disease given its overt vascular phenotype. Yet over the past years, considerable evidence suggests that central neurons in the retina also contribute to disease progression and hence DR presents salient feature of neurodegenerative disease.
Current dogma on neurodegenerative diseases dictates that once a central neuron cumulates damage and ceases to transmit sensory stimuli, it degenerates and dies an apoptotic death. Yet, from an evolutionary standpoint, survival advantage would be gained from a mechanism triggered to help weather stressors and preserve nervous tissue integrity, eventually allowing for repair and restoration of function. My host lab (Dr. Sapieha Lab's) has recently identified a new stress response system in DR, where retinal neurons, microglia and endothelial cells enter a state of premature cellular senescence. This state of the retina contributes to disease progression through generation of a series of inflammatory mediators collectively termed the senescence-associated secretory phenotype. On the other hand, why retinal neurons enter a state of premature senescence during diabetes and whether this is a protective mechanism is not understood.
In the proposed research program, we explore a novel paradigm of neuronal dormancy, where retinal neurons enter a state reversible senescence to weather diabetic and ischemic stressors. This challenges two dogmas: 1-Cellular senescence is irreversible. 2- Central neurons such as retinal ganglion cells in the retina have the inherent capacity to enter a state of dormancy to activate programs of cellular repair. Understanding the fundamental mechanisms that lead to the induction and reversal of cellular senescence may have broad implications for diabetes, and that beyond the retina.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
374382
Name
Hata Masayuki
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Cellular senescence in diabetic retinopathy
Programtype2
Fellowship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Cellular Senescence; Central Nervous System (Cns); Diabetic Retinopathy (Dr); Ischemic/Metabolic Stress; Neuronal Dormancy; Retinal Ganglion Neurons (Rgcs)
Abstract
Diabetic retinopathy (DR) is the most prominent complication of diabetes and the leading cause of severe visual loss. Diabetic retinopathy has largely been perceived as a microvascular disease given its overt vascular phenotype. Yet over the past years, considerable evidence suggests that central neurons in the retina also contribute to disease progression and hence DR presents salient feature of neurodegenerative disease.
Current dogma on neurodegenerative diseases dictates that once a central neuron cumulates damage and ceases to transmit sensory stimuli, it degenerates and dies an apoptotic death. Yet, from an evolutionary standpoint, survival advantage would be gained from a mechanism triggered to help weather stressors and preserve nervous tissue integrity, eventually allowing for repair and restoration of function. My host lab (Dr. Sapieha Lab's) has recently identified a new stress response system in DR, where retinal neurons, microglia and endothelial cells enter a state of premature cellular senescence. This state of the retina contributes to disease progression through generation of a series of inflammatory mediators collectively termed the senescence-associated secretory phenotype. On the other hand, why retinal neurons enter a state of premature senescence during diabetes and whether this is a protective mechanism is not understood.
In the proposed research program, we explore a novel paradigm of neuronal dormancy, where retinal neurons enter a state reversible senescence to weather diabetic and ischemic stressors. This challenges two dogmas: 1-Cellular senescence is irreversible. 2- Central neurons such as retinal ganglion cells in the retina have the inherent capacity to enter a state of dormancy to activate programs of cellular repair. Understanding the fundamental mechanisms that lead to the induction and reversal of cellular senescence may have broad implications for diabetes, and that beyond the retina.
Competitiondate
201709
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Hata, Masayuki
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~